Ketamine shows promise for rapid suicide prevention in youth

NCT ID NCT04763343

Recruiting now Symptom relief Sponsor: Tatiana Falcone, MD Source: ClinicalTrials.gov ↗

First seen Oct 31, 2025 · Last updated May 23, 2026 · Updated 27 times

Summary

This study tests whether ketamine can quickly lower severe suicide risk in young people aged 14 to 30 who have recently attempted suicide. Participants receive up to six infusions of ketamine or a placebo while in the hospital, plus weekly therapy sessions. The goal is to see if ketamine helps reduce suicidal thoughts faster and keeps patients engaged in long-term care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SUICIDE, ATTEMPTED are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Massachusetts General Hospital
RECRUITING

Boston, Massachusetts, 02115, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
The Cleveland Clinic
RECRUITING

Cleveland, Ohio, 44195, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

SUICIDE, ATTEMPTED